Wikidata

(Q63322886)

English

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis

clinical trial

In more languages

Statements

short name
ASCEND in SPMS (English)
0 references
title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis, With Optional Open-Label Extension (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Belgium
0 references
Canada
0 references
Denmark
0 references
Finland
0 references
France
0 references
Germany
0 references
Republic of Ireland
0 references
Israel
0 references
Italy
0 references
Netherlands
0 references
Poland
0 references
Spain
0 references
Sweden
0 references
United Kingdom
0 references
start time
13 September 2011
0 references
end time
28 July 2015
0 references
number of participants
889
0 references
minimum age
18 year
0 references
maximum age
58 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63322886&oldid=1857144850"